🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/11/2001 | 61,99 | 62,55 | 61,58 | 61,70 | -0,35% | 1,55% | 5.424.029 |
| 14/11/2001 | 61,91 | 62,52 | 61,36 | 61,92 | +0,48% | 1,87% | 5.106.170 |
| 13/11/2001 | 61,48 | 62,08 | 60,83 | 61,62 | +0,31% | 2,03% | 6.104.810 |
| 12/11/2001 | 61,16 | 61,83 | 60,59 | 61,43 | -0,36% | 2,03% | 4.527.674 |
| 09/11/2001 | 62,21 | 62,77 | 61,50 | 61,65 | -0,94% | 2,04% | 3.435.973 |
| 08/11/2001 | 61,88 | 62,78 | 61,62 | 62,23 | +0,74% | 1,87% | 4.401.286 |
| 07/11/2001 | 62,44 | 63,11 | 61,50 | 61,77 | -1,07% | 2,58% | 4.094.431 |
| 06/11/2001 | 61,64 | 62,61 | 61,17 | 62,44 | +0,09% | 2,32% | 4.829.603 |
| 05/11/2001 | 62,53 | 63,18 | 62,18 | 62,39 | +0,54% | 1,60% | 4.201.013 |
| 02/11/2001 | 61,07 | 62,26 | 61,07 | 62,05 | +1,29% | 1,95% | 4.358.527 |
| 01/11/2001 | 60,89 | 61,93 | 60,52 | 61,26 | +0,61% | 2,32% | 5.825.832 |
| 31/10/2001 | 61,77 | 61,98 | 60,88 | 60,89 | -1,45% | 1,79% | 4.336.729 |
| 30/10/2001 | 62,04 | 62,17 | 61,05 | 61,78 | -0,74% | 1,80% | 4.206.777 |
| 29/10/2001 | 62,50 | 63,04 | 62,17 | 62,24 | -0,87% | 1,40% | 3.185.710 |
| 26/10/2001 | 63,41 | 63,42 | 62,60 | 62,79 | -1,04% | 1,29% | 4.195.878 |
| 25/10/2001 | 63,36 | 64,21 | 62,29 | 63,44 | -0,76% | 3,03% | 4.859.366 |
| 24/10/2001 | 63,17 | 64,69 | 63,13 | 63,93 | +0,07% | 2,48% | 4.010.486 |
| 23/10/2001 | 65,08 | 65,08 | 63,46 | 63,88 | -0,46% | 2,48% | 4.187.494 |
| 22/10/2001 | 62,40 | 64,57 | 62,39 | 64,18 | +2,88% | 3,50% | 6.177.331 |
| 19/10/2001 | 63,22 | 63,26 | 61,78 | 62,39 | -1,39% | 2,34% | 7.150.714 |
| 18/10/2001 | 64,55 | 64,84 | 63,04 | 63,26 | -3,98% | 2,78% | 7.446.145 |
| 17/10/2001 | 65,66 | 66,46 | 65,27 | 65,89 | -0,38% | 1,82% | 5.373.096 |
| 16/10/2001 | 66,79 | 67,37 | 65,55 | 66,14 | -0,91% | 2,71% | 4.739.370 |
| 15/10/2001 | 65,65 | 66,79 | 65,65 | 66,75 | +1,14% | 1,74% | 4.266.722 |
| 12/10/2001 | 65,12 | 66,11 | 64,76 | 65,99 | +1,44% | 2,07% | 5.057.858 |
| 11/10/2001 | 65,31 | 65,46 | 64,45 | 65,06 | -0,45% | 1,55% | 5.534.174 |
| 10/10/2001 | 64,63 | 66,03 | 64,29 | 65,35 | +0,82% | 2,69% | 4.204.366 |
| 09/10/2001 | 65,17 | 65,33 | 64,06 | 64,82 | -0,98% | 1,95% | 3.728.050 |
| 08/10/2001 | 64,84 | 65,84 | 64,68 | 65,46 | +0,50% | 1,80% | 3.677.013 |
| 05/10/2001 | 64,03 | 65,27 | 63,69 | 65,13 | +1,73% | 2,46% | 4.935.242 |